A post by @FirstSquawk on X.
TRUMP SAYS LILLY HAS BROKEN GROUND IN PENNSYLVANIA’S LEHIGH VALLEY ON A $3.5 BLN SITE TO MAKE NEXT-GENERATION OBESITY MEDICINES, THE LATEST OF 10 NEW U.S. SITES SINCE 2020 - TRUTH SOCIAL
@FirstSquawk on X
Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.
Eli Lilly has broken ground on a $3.5 billion manufacturing site in Pennsylvania’s Lehigh Valley, according to a Truth Social post from President Trump, with the facility slated to produce next-generation obesity medicines. The project marks the latest of 10 new U.S. sites the company has announced since 2020. The investment underscores Lilly’s push to expand domestic production capacity as demand for obesity and diabetes treatments continues to outpace supply. Details on the site’s timeline, capacity and product mix have yet to be disclosed.
Muhabbit's AI wrote this summary of @FirstSquawk's post in its own words. It can get details wrong, so read the post on X.
Named in this story
Eli Lilly (LLY), Donald Trump, Lehigh Valley, Pennsylvania, Truth Social
A linked name opens that asset's sentiment page.